A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Clinical trial NCT06551142 · RECRUITING
Trial details
- NCT number
- NCT06551142
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2028-10-16
- Enrollment
- 845
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.